Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675714 · ClinicalTrials.gov registry record · Phase 2
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,126
- Enrollment target
NCT00675714: Clinical Trial Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT00675714 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1,126 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (747% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675714, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,126 participants
- Enrollment target
Study Summary
The purpose of the program is to study and characterize the outcome of burn injury with particular attention to improving the rehabilitation of burn survivors, including children. Various agents are assessed for effectiveness on long term burn outcome, such as growth hormone, oxandrolone, propranolol,ketoconazole, inhospital exercise and home exercise.
Primary Outcome
Dual Energy X-Ray Absorptiometry measurements will be utilized to measure muscle wasting
Interventions
- DRUG Ketoconazole
- DRUG Humatrope
- PROCEDURE Stable Isotope Infusion Study
- PROCEDURE Collection of blood and tissues
- PROCEDURE Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,126 participants |
| Start Date | 2004-01 |
| Est. Completion | 2019-07-15 |
| Phase | Phase 2 |
Why NCT00675714 stopped before completion
NCT00675714 is an interventional study that assigns participants to a tested intervention. Its 1,126 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (747% higher).
The record links to 0 conditions, and to 5 interventions - of which Ketoconazole is the first listed.
NCT00675714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00675714 about?
NCT00675714 is a clinical study titled "Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation". The purpose of the program is to study and characterize the outcome of burn injury with particular attention to improving the rehabilitation of burn survivors, including children. Various agents are assessed for effectiveness on long term burn outcome, such as growth hormone, oxandrolone, propranolo...
What is the current status of trial NCT00675714?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,126 participants. The study started on 2004-01. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT00675714?
The interventions under investigation include: Ketoconazole (DRUG), Humatrope (DRUG), Stable Isotope Infusion Study (PROCEDURE), Collection of blood and tissues (PROCEDURE), Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00675714?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00675714's enrollment target sits among peer trials
1,126 20th of 2000 higher than 1,981 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
- NCT04421768 · 1,125 participants · NA
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
- NCT06895148 · 1,125 participants · NA
ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia